Erik W Thompson Selected Research

Matrix Metalloproteinase 2 (Gelatinase A)

1/2014	High threshold of β1 integrin inhibition required to block collagen I-induced membrane type-1 matrix metalloproteinase (MT1-MMP) activation of matrix metalloproteinase 2 (MMP-2).
1/2004	Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erik W Thompson Research Topics

Disease

63	Neoplasms (Cancer) 11/2022 - 07/2002
50	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2002
24	Neoplasm Metastasis (Metastasis) 11/2020 - 04/2002
14	Hypoxia (Hypoxemia) 01/2020 - 05/2006
7	Carcinoma (Carcinomatosis) 06/2021 - 03/2003
6	Ovarian Neoplasms (Ovarian Cancer) 05/2014 - 06/2007
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2005
4	Circulating Neoplastic Cells 01/2020 - 11/2015
3	Disease Progression 01/2022 - 01/2019
3	Triple Negative Breast Neoplasms 01/2022 - 02/2019
3	Carcinogenesis 11/2020 - 07/2005
3	Inflammation (Inflammations) 01/2020 - 12/2007
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2021 - 12/2006
2	Ascites 05/2014 - 01/2012
2	Residual Neoplasm 05/2014 - 10/2011
2	Wounds and Injuries (Trauma) 05/2006 - 09/2002
2	Transitional Cell Carcinoma 03/2006 - 01/2005
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2020

Drug/Important Bio-Agent (IBA)

15	Epidermal Growth Factor (EGF)IBA 12/2020 - 03/2003
9	Proteins (Proteins, Gene)FDA Link 11/2022 - 09/2005
9	VimentinIBA 01/2020 - 01/2007
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 12/2007
7	Cadherins (E-Cadherin)IBA 11/2017 - 03/2003
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2007
6	Messenger RNA (mRNA)IBA 01/2016 - 01/2012
6	Matrix Metalloproteinases (MMPs)IBA 05/2007 - 01/2004
5	Phenobarbital (Luminal)FDA Link 06/2021 - 11/2006
5	CollagenIBA 01/2021 - 07/2004
5	CytokinesIBA 01/2020 - 07/2004
5	Matrix Metalloproteinase 14 (MT1-MMP)IBA 11/2008 - 07/2004
4	AndrogensIBA 01/2022 - 02/2005
4	CalciumIBA 12/2020 - 07/2013
4	Pharmaceutical PreparationsIBA 11/2020 - 07/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 04/2020 - 03/2013
3	Ion Channels (Ion Channel)IBA 12/2020 - 07/2017
3	Small Interfering RNA (siRNA)IBA 12/2020 - 01/2016
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2020 - 04/2015
3	OsteonectinIBA 01/2020 - 09/2002
3	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2015
3	Purinergic Receptors (Receptors, Purine)IBA 01/2016 - 01/2011
3	Adenosine Triphosphate (ATP)IBA 01/2016 - 01/2011
3	Phosphotransferases (Kinase)IBA 05/2015 - 07/2009
3	Biological ProductsIBA 03/2012 - 05/2007
2	Calcium Channels (Calcium Channel)IBA 12/2020 - 07/2013
2	IntegrinsIBA 12/2020 - 02/2004
2	Oxygen (Dioxygen)IBA 11/2020 - 11/2013
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Epithelial Cell Adhesion MoleculeIBA 06/2019 - 01/2012
2	Indicators and Reagents (Reagents)IBA 01/2019 - 07/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017 - 04/2015
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 01/2015
2	Hormones (Hormone)IBA 01/2015 - 12/2007
2	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 05/2014 - 01/2014
2	PlatinumIBA 05/2014 - 10/2011
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2014 - 01/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 05/2006
2	Transforming Growth Factor beta (TGF-beta)IBA 10/2013 - 07/2004
2	Cisplatin (Platino)FDA LinkGeneric 03/2013 - 10/2011
2	Conditioned Culture MediaIBA 04/2012 - 01/2007
2	Interleukin-6 (Interleukin 6)IBA 04/2012 - 02/2005
2	ParaffinIBA 02/2010 - 01/2006
2	Peptide Hydrolases (Proteases)FDA Link 11/2008 - 07/2004
2	Integrin beta3 (GPIIIa)IBA 05/2007 - 02/2004
2	matrigelIBA 11/2006 - 07/2004
1	ProteomeIBA 11/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	Neuropilin-1IBA 01/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	ClaudinsIBA 01/2022
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2022
1	Galectin 3 (LGALS3)IBA 05/2021
1	diethylstilbestrol monophosphate (PDES)IBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	integrin-linked kinaseIBA 12/2020
1	NitrogenIBA 11/2020
1	NitritesIBA 11/2020
1	adenylyl(3'-5')cytidine-3'-phosphateIBA 10/2020
1	diazonaphthalenedisulfonic acid (NDS)IBA 10/2020
1	Zinc Finger NucleasesIBA 06/2020
1	Transcription Activator-Like Effector NucleasesIBA 06/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2020
1	eribulin FDA Link 04/2020
1	Docetaxel (Taxotere)FDA Link 04/2020
1	Epirubicin (Ellence)FDA LinkGeneric 04/2020
1	Alkylating AgentsIBA 04/2020
1	AnthracyclinesIBA 04/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2020
1	MyokinesIBA 01/2020
1	ThapsigarginIBA 01/2020

Therapy/Procedure

28	Therapeutics 01/2022 - 04/2002
8	Drug Therapy (Chemotherapy) 01/2019 - 03/2012
3	Transplantation 05/2014 - 03/2013
2	Radiotherapy 09/2019 - 03/2012
1	Chemoprevention 10/2022
1	Castration 01/2022
1	Precision Medicine 01/2021
1	Immunotherapy 06/2020